In addition, tumor tissues treated with miR-34a showed a significantly decreased immunostaining of Ki67 and PCNA, suggesting the in vivo anti-proliferation effect of miR-34a (Figure 7B–7C). The gene discussed is PCNA; the disease is neoplasm.